Scynexis (SCYX) Cash & Current Investments (2013 - 2026)

Scynexis (SCYX) posted Cash & Current Investments of $36.8 million for Q1 2026, up 72.22% on a QoQ basis from $21.3 million in Q4 2025, and down 32.24% year-over-year from $54.2 million in Q1 2025.

Scynexis (SCYX) Cash & Current Investments (2013 - 2026) Analysis & Trends

Scynexis' Cash & Current Investments history runs 14 years deep, the most recent figure standing at $36.8 million for Q1 2026.

  • Quarterly Cash & Current Investments fell 32.24% year-over-year to $36.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.8 million (down 32.24% YoY) and the FY2025 annual result came in at $21.3 million, up 29.44% from the prior year.
  • Cash & Current Investments was $36.8 million for Q1 2026 at Scynexis, up from $21.3 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $130.7 million in Q2 2024 and bottomed at $16.5 million in Q4 2024.
  • A 5-year average of $59.8 million and a median of $44.8 million in 2025 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2023 — Cash & Current Investments surged 53.74% — and 2024, when it sank 72.38%.
  • Scynexis' Cash & Current Investments stood at $73.5 million in 2022, then tumbled by 53.16% to $34.4 million in 2023, then sank by 52.12% to $16.5 million in 2024, then gained by 29.44% to $21.3 million in 2025, then surged by 72.22% to $36.8 million in 2026.
  • Business Quant data shows SCYX's Cash & Current Investments at $36.8 million in Q1 2026, $21.3 million in Q4 2025, and $38.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 3.74 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 428.00 Mn
10 Scynexis 23.19 Mn -13.57 Mn - 36.75 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 36.75 Mn
Dec 31, 2025 21.34 Mn
Sep 30, 2025 37.98 Mn
Jun 30, 2025 44.79 Mn
Mar 31, 2025 54.24 Mn
Dec 31, 2024 16.49 Mn
Sep 30, 2024 29.17 Mn
Jun 30, 2024 130.74 Mn
Mar 31, 2024 35.86 Mn
Dec 31, 2023 34.43 Mn
Sep 30, 2023 105.58 Mn
Jun 30, 2023 85.54 Mn
Mar 31, 2023 26.97 Mn
Dec 31, 2022 73.50 Mn
Sep 30, 2022 68.68 Mn
Jun 30, 2022 118.70 Mn
Mar 31, 2022 95.21 Mn
Dec 31, 2021 104.48 Mn
Sep 30, 2021 100.11 Mn
Jun 30, 2021 112.46 Mn